Concepedia

Binoy Kar

BK

Statistics

Publications

13

Citations

370

H-Index

12

Active since

2020

Affiliations

Vellore Institute of Technology University(Current)

Yenepoya University

Sardar Vallabhbhai National Institute of Technology Surat

Rajiv Gandhi Institute of Petroleum Technology

Binoy Kar is an author at Vellore Institute of Technology University specializing in ligand binding, oncology, and cancer pharmacology.

Publications per year

2020–2025

13

Publications

13

Recent advances on organelle specific Ru(II)/Ir(III)/Re(I) based complexes for photodynamic therapy

Binoy Kar, Utpal Das, Nilmadhab Roy et al. · Coordination Chemistry Reviews · 2022 · 105 citations

Natural Sciences, Chemistry, Materials Science +12

Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy

Sudhindra Pete, Nilmadhab Roy, Binoy Kar et al. · Coordination Chemistry Reviews · 2022 · 52 citations

Pharmacy, Medicinal Chemistry, Oncology +13

Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals

Binoy Kar, Nilmadhab Roy, Sudhindra Pete et al. · Inorganica Chimica Acta · 2020 · 42 citations

Natural Sciences, Chemistry, Oncology +11

GSH-resistant and highly cytoselective ruthenium(<scp>ii</scp>)-<i>p</i>-cymene-(imidazo[4,5-<i>f</i>][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agents

Binoy Kar, Utpal Das, Sourav De et al. · Dalton Transactions · 2021 · 28 citations

Medicine, Medicinal Chemistry, Oncology +11

G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells

Nilmadhab Roy, Shanooja Shanavas, Binoy Kar et al. · ACS Omega · 2023 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 13